BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Björnsson HK, Olafsson S, Bergmann OM, Björnsson ES. A prospective study on the causes of notably raised alanine aminotransferase (ALT). Scandinavian Journal of Gastroenterology 2016;51:594-600. [DOI: 10.3109/00365521.2015.1121516] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Cheng SQ. Influence of non-pathological factors on ALT measurements. Shijie Huaren Xiaohua Zazhi 2017; 25(34): 3005-3020 [DOI: 10.11569/wcjd.v25.i34.3005] [Reference Citation Analysis]
2 Ogunmoyole T, Dada I, Adebamigbe OA. Ameliorative potentials of Persea americana leaf extract on toxicants - induced oxidative assault in multiple organs of wistar albino rat. Clin Phytosci 2021;7. [DOI: 10.1186/s40816-020-00237-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Quickert S, Reuken PA, Rose M, Boden K, Bruns T. Acute Hepatitis E is an Underreported Cause of Severe Acute Liver Injury. Clinical Gastroenterology and Hepatology 2019;17:1004-6. [DOI: 10.1016/j.cgh.2018.09.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 155] [Article Influence: 66.0] [Reference Citation Analysis]
5 Valgeirsson KB, Hreinsson JP, Björnsson ES. Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver Int 2019;39:2341-9. [PMID: 31436903 DOI: 10.1111/liv.14224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Breu AC, Patwardhan VR, Nayor J, Ringwala JN, Devore ZG, Ganatra RB, Hathorn KE, Horton L, Iriana S, Tapper EB. A Multicenter Study Into Causes of Severe Acute Liver Injury. Clin Gastroenterol Hepatol 2019;17:1201-3. [PMID: 30103039 DOI: 10.1016/j.cgh.2018.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Cano-paniagua A, Amariles P, Angulo N, Restrepo-garay M. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment. Annals of Hepatology 2019;18:501-7. [DOI: 10.1016/j.aohep.2018.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
8 Jonsdottir S, Arnardottir MB, Andresson JA, Bjornsson HK, Lund SH, Bjornsson ES. Prevalence, clinical characteristics and outcomes of hypoxic hepatitis in critically ill patients. Scand J Gastroenterol 2021;:1-8. [PMID: 34846975 DOI: 10.1080/00365521.2021.2005136] [Reference Citation Analysis]
9 Schmilovitz-Weiss H, Gingold-Belfer R, Grossman A, Issa N, Boltin D, Beloosesky Y, Morag Koren N, Meyerovitch J, Weiss A. Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly. PLoS One 2019;14:e0212737. [PMID: 30973940 DOI: 10.1371/journal.pone.0212737] [Reference Citation Analysis]
10 Björnsson HK, Björnsson ES. A significant proportion of patients with choledocholithiasis have markedly elevated alanine aminotransferase. Scand J Gastroenterol 2019;54:1155-9. [PMID: 31479284 DOI: 10.1080/00365521.2019.1657177] [Reference Citation Analysis]
11 Curra M, Gabriel AF, Ferreira MBC, Martins MAT, Brunetto AT, Gregianin LJ, Martins MD. Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy. Support Care Cancer 2021. [PMID: 33846825 DOI: 10.1007/s00520-021-06199-5] [Reference Citation Analysis]
12 Björnsson ES, Bergmann O, Jonasson JG, Grondal G, Gudbjornsson B, Olafsson S. Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids. Clinical Gastroenterology and Hepatology 2017;15:1635-6. [DOI: 10.1016/j.cgh.2017.05.027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
13 Bunchorntavakul C, Reddy KR. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver. Gastroenterol Clin North Am 2020;49:331-46. [PMID: 32389366 DOI: 10.1016/j.gtc.2020.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Li X, Zhou TC, Wu CH, Tao LL, Bi R, Chen LJ, Deng DY, Liu C, Otecko NO, Tang Y, Lai X, Zhang L, Wei J. Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, China. Sci Rep 2018;8:869. [PMID: 29343698 DOI: 10.1038/s41598-018-19184-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
16 Leonardsson H, Hreinsson JP, Löve A, Björnsson ES. Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes. Scand J Gastroenterol 2017;52:893-7. [PMID: 28446048 DOI: 10.1080/00365521.2017.1319972] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Björnsson ES. Clinical management of patients with drug-induced liver injury (DILI). United European Gastroenterol J 2021;9:781-6. [PMID: 35084797 DOI: 10.1002/ueg2.12113] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Aboelsoud MM, Javaid AI, Al-Qadi MO, Lewis JH. Hypoxic hepatitis - its biochemical profile, causes and risk factors of mortality in critically-ill patients: A cohort study of 565 patients. J Crit Care 2017;41:9-15. [PMID: 28460210 DOI: 10.1016/j.jcrc.2017.04.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
19 McGill MR, Jaeschke H. Biomarkers of drug-induced liver injury. Adv Pharmacol 2019;85:221-39. [PMID: 31307588 DOI: 10.1016/bs.apha.2019.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Liu M, Tan W, Yuan W, Wang T, Lu X, Liu N. Development and Validation of a Diagnostic Model to Predict the Risk of Ischemic Liver Injury After Stanford A Aortic Dissection Surgery. Front Cardiovasc Med 2021;8:701537. [PMID: 34631813 DOI: 10.3389/fcvm.2021.701537] [Reference Citation Analysis]
21 Björnsson HK, Björnsson ES. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management. Eur J Intern Med 2021:S0953-6205(21)00375-7. [PMID: 34772600 DOI: 10.1016/j.ejim.2021.10.035] [Reference Citation Analysis]